Frontlight ResearchEarly access
WithdrawnNo phase
IRIS-Firehawk® Cohort in the IRIS-DES Registry
Key facts
- Who runs it
- Duk-Woo Park, MD
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Withdrawn
- Started
- Mar 2018
- Ended
- Dec 2025
- Type of study
- Observational
- Treatments tested
- Firehawk
- Record updated
- 9 March 2018
- Why it stopped
- Funding issue
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- Age 19 and more
- Patient with Firehawk® coronary stent
Who cannot take part
- Intervention with Firehawk® coronary stent and other drug eluting stent at the same time
- Cardiac shock
- Life-expectancy less than 1 year
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The objective of this study is to evaluate effectiveness and safety of Firehawk® stent in the "real world" daily practice as compared with other drug-eluting stents.
The group in the trial
- Coronary Stenosis
Treatment: Firehawk
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of Effectiveness and Safety of Firehawk® Stent in Routine Clinical Practice; A Multicenter, Prospective Observational Study
- Record updated
- 9 March 2018